Performance status is a standardised measure of how well a patient is able to carry out daily activities. It is one of the most consistently used eligibility criteria in oncology - including for pembrolizumab - because it provides a practical measure of a patient's physiological reserve and ability to tolerate treatment.
The ECOG performance status scale
The most widely used system is the Eastern Cooperative Oncology Group (ECOG) scale, which grades patients from 0 to 4:
- ECOG 0: Fully active. Able to carry on all normal activity without restriction.
- ECOG 1: Restricted in physically strenuous activity, but ambulatory and able to carry out light housework or office work.
- ECOG 2: Ambulatory and capable of self-care, but unable to carry out any work activity. Up and about more than 50% of waking hours.
- ECOG 3: Capable of only limited self-care. Confined to bed or chair more than 50% of waking hours.
- ECOG 4: Completely disabled. Confined to bed or chair. Cannot carry out any self-care.
Most pembrolizumab clinical trials enrolled patients with ECOG 0 or 1. Some trials included ECOG 2 patients; very few included ECOG 3 or 4.
Why performance status matters for pembrolizumab
Patients with poor performance status have less physiological reserve - they are less able to tolerate immune-related adverse events and less likely to benefit from treatment. The evidence base for pembrolizumab is largely derived from ECOG 0-1 populations, which is why most treatment guidelines specify these grades for routine use. For patients with ECOG 2, clinical judgement on a case-by-case basis determines whether the risk-benefit balance supports treatment.
Performance status can change
Performance status is not fixed. A patient who is ECOG 2 due to cancer-related symptoms may improve to ECOG 1 with supportive care. Conversely, performance status can decline as disease progresses. It is assessed at the time of each treatment decision - not once at diagnosis and then assumed to be stable.
If you are currently at ECOG 2 and your oncologist has suggested you may not be suitable for treatment, it may be worth discussing whether any reversible factors are contributing to your current functional status.
Unsure of your performance status?
Describe your day-to-day function in the eligibility check - our reviewing oncologist will assess performance status from the information you provide.
Check your eligibility